National Eye Institute; Notice of Meeting, 57500-57501 [2022-20287]
Download as PDF
<![CDATA[
57500
Federal Register / Vol. 87, No. 181 / Tuesday, September 20, 2022 / Notices
Open: 9:45 a.m. to 11:30 a.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institutes of Health,
National Institute on Aging, Biomedical
Research Center, 251 Bayview Boulevard,
Baltimore, MD 21224 (Virtual Meeting).
Closed: 11:30 a.m. to 1 p.m.
Agenda: Executive Session.
Place: National Institutes of Health,
National Institute on Aging, Biomedical
Research Center, 251 Bayview Boulevard,
Baltimore, MD 21224 (Virtual Meeting).
Contact Person: Luigi Ferrucci, Ph.D., MD,
Scientific Director, National Institute on
Aging, 251 Bayview Boulevard, Suite 100,
Room 4C225, Baltimore, MD 21224, 410–
558–8110, LF27Z@NIH.GOV.
Information is also available on the
Institute’s/Center’s home page:
www.nia.nih.gov/, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS.)
Dated: September 15, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Songtao Liu, MD,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 920, MSC 5469,
Bethesda, MD 20817, (301) 827–3025,
songtao.liu@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health.)
Dated: September 15, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–20286 Filed 9–19–22; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting of the National
Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 NCBIB Review
H–SEP.
Date: October 26–27, 2022.
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:48 Sep 19, 2022
Jkt 256001
Dated: September 15, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–20281 Filed 9–19–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
[FR Doc. 2022–20282 Filed 9–19–22; 8:45 am]
BILLING CODE 4140–01–P
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS.)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Diabetes,
Endocrinology and Metabolic Diseases B
Study Section.
Date: October 26–28, 2022.
Time: 10 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Suite 7017, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Charlene J. Repique, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7347, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–7791,
charlene.repique@nih.gov.
Information is also available on the
Institute’s/Center’s home page:
www.niddk.nih.gov/, where an agenda and
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
National Eye Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Eye
Council.
The meeting will be held as a virtual
meeting on October 14, 2022 and is
open to the public as indicated below.
The open session (event) will be
videocast by NIH with closed captioning
at: https://videocast.nih.gov/
watch=46066. To request reasonable
accommodations, please contact
Nathan.Brown2@nih.gov at least five
days before the event. The agenda can
be found at: https://www.nei.nih.gov/
about/advisory-committees/nationaladvisory-eye-council-naec/nationaladvisory-eye-council-naec-meetingagenda.
A portion of this meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Eye Council.
Date: October 14, 2022.
Open: 10 a.m. to 2:30 p.m.
Agenda: Presentation of the NEI Director’s
report and discussion of NEI programs.
Place: National Eye Institute, National
Institutes of Health, 6700 Rockledge Drive,
Suite 3400, Bethesda, MD 20892 (Virtual
Meeting).
Closed: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\20SEN1.SGM
20SEN1
Federal Register / Vol. 87, No. 181 / Tuesday, September 20, 2022 / Notices
Place: National Eye Institute, National
Institutes of Health, 6700 Rockledge Drive,
Suite 3400, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Kathleen C. Anderson,
Ph.D., Director, Division of Extramural
Activities, National Eye Institute, National
Institutes of Health, 6700B Rockledge Drive,
Room 3440, Bethesda, MD 20892, (301) 451–
2020, kanders1@nei.nih.gov.
Information is also available on the NEI
Council page: https://www.nei.nih.gov/about/
advisorye-council-naec, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS.)
Dated: September 13, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–20287 Filed 9–19–22; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award
supplemental funding.
AGENCY:
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
lotter on DSK11XQN23PROD with NOTICES1
[FR Doc. 2022–20237 Filed 9–19–22; 8:45 am]
Fiscal Year (FY) 2022 Notice of
Supplemental Funding Opportunity
National Institutes of Health
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of SuRE Applications.
Date: November 14–15, 2022.
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John J. Laffan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN18J, Bethesda,
MD 20892, 301–594–2773, laffanjo@
mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page:
www.nigms.nih.gov/, where an agenda and
19:08 Sep 19, 2022
Dated: September 14, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Substance Abuse and Mental Health
Services Administration
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS.)
Jkt 256001
SUMMARY: This notice is a notice of
intent to award supplemental funding to
the nine Minority Fellowship recipients
funded in FY 2018 under Notice of
Funding Opportunity (NOFO) SM–18–
002 and TI–18–013 and in FY 2020
under NOFO SM–20–013. This is to
inform the public that the Substance
Abuse and Mental Health Services
Administration (SAMHSA) is
supporting one-year administrative
supplements, which are consistent with
the initial award, up to $209,996 each
for eight Minority Fellowship Program
(MFP) recipients funded under NOFO
SM–18–002 and SM–20–013, and up to
$119,053 for the MFP recipient funded
under NOFO TI–18–013, for a total of
$1,799,019.
FOR FURTHER INFORMATION CONTACT:
Sheryl Crawford, Center for Substance
Abuse Treatment, SAMHSA, 5600
Fishers Lane, Rockville, MD 20857,
telephone (240) 276–1063; email:
sheryl.crawford@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION: The MFP
program is comprised of professional
organizations representing mental and
substance use disorder treatment
professionals in the fields of psychiatry,
nursing, social work, psychology,
marriage and family therapy, mental
health counseling, substance use
disorder and addiction counseling and
addiction psychiatry and medicine. This
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
57501
supplement will enhance and increase
the behavioral health workforce
knowledge related to prevention,
treatment, and recovery support for
mental illness and substance use
disorders among racial and ethnic
minority populations by providing
specialized training among the MFP
professional organizations. Assistance
will only be provided to the nine MFP
recipients, which were funded in FY
2018 under SM–18–002 and TI–18–002
with a project end date of September 29,
2023, and FY 2020 under SM–20–013
with a project end date of August 30,
2025.
This is not a formal request for
application. Assistance will only be
provided to the nine MFP grant
recipients, based on the receipt of a
satisfactory application and associated
budget that is approved by a review
group.
Funding Opportunity Title: FY 2018
Minority Fellowship Program (MFP)
NOFO SM–18–022 and TI–18–013 and
FY 2020 MFP NOFO SM–20–013.
Assistance Listing Number: 93.243.
Authority: The MFP is authorized
under section 597 of the Public Health
Service Act, as amended.
Justification: Eligibility for this
supplemental funding is limited to the
nine MFP organizations funded in FY
2018 and FY 2020. These organizations
have the required expertise to provide
specialized training to increase
behavioral health professionals’
knowledge related to prevention,
treatment, and recovery support for
mental illness and substance use
disorders among racial and ethnic
minority populations.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022–20321 Filed 9–19–22; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2022–0345]
Certificate of Alternative Compliance
for the GUNDERSON MARINE OIL
SPILL RECOVERY BARGE (OSRB–5),
HULL NO 129
Coast Guard, DHS.
Notification of issuance of a
certificate of alternative compliance.
AGENCY:
ACTION:
SUMMARY: The Coast Guard announces
that the Chief, Prevention Division,
Thirteenth Coast Guard District has
issued a certificate of alternative
E:\FR\FM\20SEN1.SGM
20SEN1
]]>Agencies
[Federal Register Volume 87, Number 181 (Tuesday, September 20, 2022)]
[Notices]
[Pages 57500-57501]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20287]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Eye Council.
The meeting will be held as a virtual meeting on October 14, 2022
and is open to the public as indicated below. The open session (event)
will be videocast by NIH with closed captioning at: https://videocast.nih.gov/watch=46066. To request reasonable accommodations,
please contact [email protected] at least five days before the
event. The agenda can be found at: https://www.nei.nih.gov/about/advisory-committees/national-advisory-eye-council-naec/national-advisory-eye-council-naec-meeting-agenda.
A portion of this meeting will be closed to the public in
accordance with the provisions set forth in sections 552b(c)(4) and
552b(c)(6), title 5 U.S.C., as amended. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Advisory Eye Council.
Date: October 14, 2022.
Open: 10 a.m. to 2:30 p.m.
Agenda: Presentation of the NEI Director's report and discussion
of NEI programs.
Place: National Eye Institute, National Institutes of Health,
6700 Rockledge Drive, Suite 3400, Bethesda, MD 20892 (Virtual
Meeting).
Closed: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
[[Page 57501]]
Place: National Eye Institute, National Institutes of Health,
6700 Rockledge Drive, Suite 3400, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Kathleen C. Anderson, Ph.D., Director, Division
of Extramural Activities, National Eye Institute, National
Institutes of Health, 6700B Rockledge Drive, Room 3440, Bethesda, MD
20892, (301) 451-2020, [email protected].
Information is also available on the NEI Council page: https://www.nei.nih.gov/about/advisorye-council-naec, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.867,
Vision Research, National Institutes of Health, HHS.)
Dated: September 13, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-20287 Filed 9-19-22; 8:45 am]
BILLING CODE 4140-01-P
